It seems like a slam dunk. Why not repurpose already approved or well-studied drug candidates for conditions where treatments are desperately needed? Wouldn’t...
Researchers at Emory investigated the use of an FDA-approved ADHD medication on patients with mild Alzheimer’s symptoms and found it appeared to reduce levels of tau.
The World Health Organization updated its guidelines for COVID-19 treatments against the use of convalescent plasma for all cases of infection.
The World Health Organization (WHO) said on Aug. 11 a clinical trial in 52 countries would study three anti-inflammatory drugs as potential treatments for Covid-19 patients.
Review of the life histories of RNA viruses, their genetics, and the compounds that could disrupt them offers hope for curtailment of future pandemics Credit: Illustration:...
Combination was uncovered from examining 12 potential drug candidates with over 530,0000 possible drug combinations within two weeks Credit: National University of Singapore A team of...
Once touted as promising treatments and by some even a cure, the World Health Organization dashes those claims, finding no benefit in the use of four popular Covid-19 treatments (remdesivir, hydroxychloroquine, lopinavir, or interferon-beta-1a)...
Initial studies suggest these drugs, widely taken to lower cholesterol, may also reduce the severity of COVID-19.
Will test a number of promising treatments in urgently needed focus on mild and moderate cases Credit: Kenny Mbala-DNDi NAIROBI/KINSHASA/GENEVA – 24 NOVEMBER 2020 Thirteen African...
Lilly’s baricitinib granted US emergency use in COVID-19
Roche’s Actemra helps sickest Covid-19 patients, study shows
The ‘failure’ of clinical trials in the search for COVID-19 treatments
Convalescent plasma misses the mark in phase 2 trial
Gilead’s Remdesivir Wins FDA’s First COVID-19 Drug Approval
Gilead’s COVID-19 drug Veklury falls short in WHO’s global trial
EU makes 1 billion euro bet on Gilead’s Covid drug before trial results
Trump’s Treatments: Regeneron’s Antibodies and Gilead’s Remdesivir Explained
Regeneron tests COVID-19 antibody therapy in UK’s RECOVERY trial
Certara adds to its COVID-19 toolkit with virtual trials module
Basel study: Why lopinavir and hydroxychloroquine do not work on COVID-19
Which drugs and therapies are proven to work, and which ones don't, for COVID-19?
3 "Strong Buy" Coronavirus Stocks With Massive Upside Potential
UK team awarded grant for ‘second wave’ COVID-19 drug hunt
Futures Spike After Study Reveals Steroid Effective Against Advanced COVID-19
Stocks Amid COVID-19 Outbreak: Winners So Far in the Health Industry